BCIQ Profiles

Company Profile Report

Kindler joins Blackstone as senior adviser; plus changes at Mission, Annexon, Dyne, Ribometrix, Autolus and more

Jeffrey Kindler has joined Blackstone Group as a senior adviser. He is the CEO of Centrexion Therapeutics Corp. and served as chairman and CEO of Pfizer Inc. (NYSE:PFE) in 2006-10.

Mission Therapeutics Ltd. promoted Paul Thompson to

Read the full 363 word article

How to gain access

Continue reading with a
two-week free trial.